Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 27,303 | 52,989 | +25,686 | $16.19M | $28.71M | 10.14% | +$12.52M |
| Revolution Medicines, Inc.(RVMD) | 80,872 | 139,218 | +58,346 | $7.86M | $26.07M | 9.21% | +$18.21M |
| ABIVAX Société AnonymeADS(ABVX) | 75,944 | 163,644 | +87,700 | $8.22M | $21.60M | 7.63% | +$13.38M |
| Cogent Biosciences, Inc.(COGT) | 322,764 | 493,664 | +170,900 | $12.42M | $19.10M | 6.75% | +$6.68M |
| BridgeBio Pharma, Inc.NOTE 1 750 3 0(BBIO) | 250,000 | 0 | -250,000 | $18.57M | $18.62M | 6.58% | +$55.0K |
| BioMarin Pharmaceutical Inc.(BMRN) | 148,229 | 312,846 | +164,617 | $8.37M | $17.90M | 6.32% | +$9.53M |
| Viking Therapeutics, Inc.(VKTX) | 525,181 | 441,808 | -83,373 | $17.09M | $17.23M | 6.09% | +$145.5K |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 272,214 | +272,214 | $0 | $11.06M | 3.91% | +$11.06M |
| Kodiak Sciences Inc.(KOD) | 192,962 | 218,117 | +25,155 | $7.36M | $8.50M | 3.00% | +$1.14M |
| Immunocore Holdings plcADS(IMCR) | 193,189 | 254,863 | +61,674 | $5.82M | $8.09M | 2.86% | +$2.27M |
| 4d Molecular Therapeutics In | 0 | 571,107 | +571,107 | $0 | $7.60M | 2.68% | +$7.60M |
| Arcus Biosciences, Inc.(RCUS) | 238,142 | 223,810 | -14,332 | $5.14M | $6.90M | 2.44% | +$1.76M |
| Johnson & Johnson(JNJ) | 53,771 | 22,000 | -31,771 | $13.14M | $5.59M | 1.97% | -$7.56M |
| Novo Nordisk A/SADR(NVO) | 14,577 | 100,000 | +85,423 | $520.7K | $4.81M | 1.70% | +$4.29M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 244,811 | 294,811 | +50,000 | $3.58M | $4.40M | 1.56% | +$822.9K |
| Relay Therapeutics, Inc.(RLAY) | 0 | 230,677 | +230,677 | $0 | $4.32M | 1.52% | +$4.32M |
| Zymeworks Inc.(ZYME) | 142,132 | 142,132 | 0 | $3.56M | $3.72M | 1.31% | +$156.3K |
| BioAge Labs, Inc.(BIOA) | 60,000 | 146,334 | +86,334 | $1.05M | $3.59M | 1.27% | +$2.54M |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 522,619 | +522,619 | $0 | $3.56M | 1.26% | +$3.56M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 121,539 | +121,539 | $0 | $2.95M | 1.04% | +$2.95M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 439,957 | 301,264 | -138,693 | $4.13M | $2.83M | 1.00% | -$1.31M |
| Indivior Pharmaceuticals, Inc.(INDV) | 71,376 | 67,512 | -3,864 | $2.18M | $2.77M | 0.98% | +$594.5K |
| Inventiva S.A.ADS(IVA) | 352,399 | 740,786 | +388,387 | $1.94M | $2.73M | 0.96% | +$790.7K |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 27,799 | +27,799 | $0 | $2.65M | 0.93% | +$2.65M |
| Vaxcyte, Inc.(PCVX) | 25,071 | 45,071 | +20,000 | $1.46M | $2.62M | 0.93% | +$1.16M |
| Relmada Therapeutics, Inc.(RLMD) | 200,842 | 361,367 | +160,525 | $1.40M | $2.50M | 0.88% | +$1.10M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 57,608 | +57,608 | $0 | $2.47M | 0.87% | +$2.47M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 119,733 | +119,733 | $0 | $1.96M | 0.69% | +$1.96M |
| Bicycle Therapeutics PlcADS | 476,424 | 462,724 | -13,700 | $2.21M | $1.96M | 0.69% | -$248.7K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 187,307 | 78,391 | -108,916 | $3.08M | $1.90M | 0.67% | -$1.18M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 100,000 | +100,000 | $0 | $1.84M | 0.65% | +$1.84M |
| MacroGenics, Inc.(MGNX) | 600,000 | 374,403 | -225,597 | $1.73M | $1.73M | 0.61% | -$4.3K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 180,083 | 926,016 | +745,933 | $291.7K | $1.72M | 0.61% | +$1.43M |
| Spruce Biosciences Inc | 10,000 | 30,000 | +20,000 | $653.5K | $1.62M | 0.57% | +$966.5K |
| Ardelyx Inc | 0 | 303,025 | +303,025 | $0 | $1.55M | 0.55% | +$1.55M |
| Cue Biopharma, Inc.(CUE) | 0 | 48,369 | +48,369 | $0 | $1.53M | 0.54% | +$1.53M |
| Mineralys Therapeutics, Inc.(MLYS) | 26,347 | 56,347 | +30,000 | $713.7K | $1.52M | 0.54% | +$806.5K |
| Prothena Corp PlcSHS SHS | 0 | 149,482 | +149,482 | $0 | $1.46M | 0.52% | +$1.46M |
| Voyager Therapeutics, Inc.(VYGR) | 423,642 | 413,642 | -10,000 | $1.64M | $1.45M | 0.51% | -$187.5K |
| Unicycive Therapeutics, Inc.(UNCY) | 106,083 | 303,676 | +197,593 | $698.0K | $1.42M | 0.50% | +$726.2K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 54,650 | 129,950 | +75,300 | $607.2K | $1.41M | 0.50% | +$802.8K |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 15,000 | +15,000 | $0 | $1.33M | 0.47% | +$1.33M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 200,000 | +200,000 | $0 | $1.32M | 0.47% | +$1.32M |
| Equillium, Inc.(EQ) | 433,844 | 400,282 | -33,562 | $867.7K | $1.28M | 0.45% | +$413.2K |
| Xeris Biopharma Holdings Inc | 132,746 | 132,746 | 0 | $769.9K | $1.05M | 0.37% | +$281.4K |
| Pharvaris N V COM | 29,321 | 29,321 | 0 | $828.3K | $1.01M | 0.36% | +$185.6K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 92,864 | 26,864 | -66,000 | $2.60M | $978.1K | 0.35% | -$1.62M |
| Cartesian Therapeutics, Inc.(RNAC) | 0 | 87,057 | +87,057 | $0 | $907.1K | 0.32% | +$907.1K |
| Rigel Pharmaceuticals, Inc.(RIGL) | 0 | 22,816 | +22,816 | $0 | $892.6K | 0.32% | +$892.6K |
| Summit Therapeutics Inc.(SMMT) | 0 | 60,000 | +60,000 | $0 | $874.2K | 0.31% | +$874.2K |
| Precigen, Inc.(PGEN) | 55,293 | 135,293 | +80,000 | $214.0K | $771.2K | 0.27% | +$557.2K |
| Definium Therapeutics, Inc.(DFTX) | 0 | 15,451 | +15,451 | $0 | $726.8K | 0.26% | +$726.8K |
| Pelthos Therapeutics Inc.(PTHS) | 24,773 | 24,773 | 0 | $520.5K | $700.1K | 0.25% | +$179.6K |
| PepGen Inc.(PEPG) | 150,925 | 373,284 | +222,359 | $267.1K | $671.9K | 0.24% | +$404.8K |
| Enliven Therapeutics Inc | 245 | 10,000 | +9,755 | $9.6K | $507.5K | 0.18% | +$497.9K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 200,690 | 196,985 | -3,705 | $525.8K | $468.8K | 0.17% | -$57.0K |
| Larimar Therapeutics, Inc.(LRMR) | 166,637 | 146,637 | -20,000 | $749.9K | $447.2K | 0.16% | -$302.6K |
| Cellectar Biosciences, Inc.(CLRB) | 0 | 138,341 | +138,341 | $0 | $384.6K | 0.14% | +$384.6K |
| Foghorn Therapeutics Inc.(FHTX) | 79,944 | 66,908 | -13,036 | $382.1K | $326.5K | 0.12% | -$55.6K |
| Aytu Biopharma Inc | 353,077 | 148,546 | -204,531 | $963.9K | $319.4K | 0.11% | -$644.5K |
| Ocugen, Inc.(OCGN) | 200,000 | 200,000 | 0 | $362.0K | $306.0K | 0.11% | -$56.0K |
| UroGen Pharma Ltd.(URGN) | 23,155 | 7,137 | -16,018 | $416.3K | $262.6K | 0.09% | -$153.7K |
| Amgen Inc.(AMGN) | 0 | 102,701 | +102,701 | $0 | $214.6K | 0.08% | +$214.6K |
| Heron Therapeutics, Inc.(HRTX) | 0 | 458,723 | +458,723 | $0 | $195.8K | 0.07% | +$195.8K |
| Talphera, Inc.(TLPH) | 153,563 | 153,563 | 0 | $114.7K | $158.2K | 0.06% | +$43.5K |
| Annexon, Inc.(ANNX) | 132,916 | 27,516 | -105,400 | $736.4K | $157.1K | 0.06% | -$579.2K |
| Monopar Therapeutics Inc.(MNPR) | 1,630 | 1,630 | 0 | $89.3K | $150.9K | 0.05% | +$61.6K |
| Lakeland Industries, Inc.(LAKE) | 0 | 14,108 | +14,108 | $0 | $150.8K | 0.05% | +$150.8K |
| Upstream Bio, Inc.(UPB) | 21,609 | 19,093 | -2,516 | $194.5K | $132.1K | 0.05% | -$62.4K |
| MeiraGTx Holdings plc(MGTX) | 0 | 8,368 | +8,368 | $0 | $113.1K | 0.04% | +$113.1K |
| Jatt Ii Acquisition Corp | 0 | 9,021 | +9,021 | $0 | $102.5K | 0.04% | +$102.5K |
| Kailera Therapeutics Inc | 0 | 3,621 | +3,621 | $0 | $79.8K | 0.03% | +$79.8K |
| MannKind Corporation(MNKD) | 186,603 | 16,003 | -170,600 | $457.2K | $68.2K | 0.02% | -$389.0K |
| Entera Bio Ltd.SHS(ENTX) | 23,260 | 23,260 | 0 | $25.8K | $41.2K | 0.01% | +$15.4K |
| ARS Pharmaceuticals, Inc.(SPRY) | 0 | 4,860 | +4,860 | $0 | $38.9K | 0.01% | +$38.9K |
| Aprea Therapeutics, Inc.(APRE) | 0 | 44,907 | +44,907 | $0 | $36.0K | 0.01% | +$36.0K |
| Tvardi Therapeutics, Inc.(TVRD) | 0 | 16,607 | +16,607 | $0 | $31.6K | 0.01% | +$31.6K |
| Nextcure Inc | 0 | 7,742 | +7,742 | $0 | $12.4K | 0.00% | +$12.4K |
| AbbVie Inc.(ABBV) | 24,058 | 0 | -24,058 | $5.23M | $0 | — | -$5.23M |
| Alkermes plcSHS(ALKS) | 50,000 | 0 | -50,000 | $1.77M | $0 | — | -$1.77M |
| Atrium Therapeutics, Inc.(RNA) | 2,512 | 0 | -2,512 | $33.6K | $0 | — | -$33.6K |
| BridgeBio Pharma, Inc.(BBIO) | 85,311 | 0 | -85,311 | $6.34M | $0 | — | -$6.34M |
| Capricor Therapeutics, Inc.(CAPR) | 78,851 | 0 | -78,851 | $2.40M | $0 | — | -$2.40M |
| Celcuity Inc.(CELC) | 5,314 | 0 | -5,314 | $606.5K | $0 | — | -$606.5K |
| Climb Bio, Inc.(CLYM) | 286,126 | 0 | -286,126 | $1.96M | $0 | — | -$1.96M |
| COMPASS Pathways plcADS(CMPS) | 31,885 | 0 | -31,885 | $176.3K | $0 | — | -$176.3K |
| Corcept Therapeutics Incorporated(CORT) | 10,000 | 0 | -10,000 | $403.1K | $0 | — | -$403.1K |
| Cue Biopharma, Inc.(CUE) | 131,997 | 0 | -131,997 | $30.3K | $0 | — | -$30.3K |
| Dianthus Therapeutics, Inc.(DNTH) | 10,000 | 0 | -10,000 | $839.2K | $0 | — | -$839.2K |
| Eli Lilly and Company(LLY) | 6,000 | 0 | -6,000 | $5.52M | $0 | — | -$5.52M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 64,952 | 0 | -64,952 | $820.3K | $0 | — | -$820.3K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 40,000 | 0 | -40,000 | $289.6K | $0 | — | -$289.6K |
| EyePoint, Inc.(EYPT) | 178,545 | 0 | -178,545 | $2.30M | $0 | — | -$2.30M |
| GH Research PLC(GHRS) | 26,836 | 0 | -26,836 | $377.3K | $0 | — | -$377.3K |
| Incyte Corporation(INCY) | 78,029 | 0 | -78,029 | $7.34M | $0 | — | -$7.34M |
| Inovio Pharmaceuticals, Inc.(INO) | 562,665 | 0 | -562,665 | $979.0K | $0 | — | -$979.0K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 54,755 | 0 | -54,755 | $10.35M | $0 | — | -$10.35M |
| Lipocine Inc.(LPCN) | 50,000 | 0 | -50,000 | $399.5K | $0 | — | -$399.5K |
| Maze Therapeutics, Inc.(MAZE) | 15,000 | 0 | -15,000 | $447.8K | $0 | — | -$447.8K |
| Passage Bio, Inc.(PASG) | 19,530 | 0 | -19,530 | $153.3K | $0 | — | -$153.3K |